Federal Register / Vol. 74, No. 195 / Friday, October 9, 2009 / Notices 52249 

DEA, NIDDK, National Institutes of Health, 

Room 750, 6707 Democracy Boulevard, 

Bethesda, MD 20892–5452, (301) 594–8886, 

edwardsm@extra.niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: October 2, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–24363 Filed 10–8–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Disorders; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.) notice is 

hereby given of the following meeting 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The purpose of this 

meeting is to evaluate requests for 

preclinical development resources for 

potential new therapeutics for type 1 

diabetes. The outcome of the evaluation 

will be a decision whether NIDDK 

should support the request and make 

available contract resources for 

development of the potential 

therapeutic to improve the treatment or 

prevent the development of type 1 

diabetes and its complications. The 

research proposals and the discussions 

could disclose confidential trade secrets 

or commercial property such as 

patentable material, and personal 

information concerning individuals 

associated with the proposed research 

projects, the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Type 1 Diabetes— 

Rapid Access to Intervention Development 

Special Emphasis Panel, National Institute of 

Diabetes and Digestive and Kidney Diseases. 

Date: October 28, 2009. 

Time: 11 a.m.–1 p.m. 

Agenda: To evaluate requests for 

preclinical development resources for 

potential new therapeutics for type 1 diabetes 

and its complications. 

Place: 6707 Democracy Boulevard, 

Bethesda, MD 20892. (Telephone Conference 

Call). 

Contact Person: Dr. Myrlelne Staten, 

Senior Advisor, Diabetes, Translation 

Research, Division of Diabetes, 

Endocrinology and Metabolic Diseases, 

NIDDK, NIH, 6707 Democracy Boulevard, 

Bethesda, MD 20892–5460, 301 402–7886. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 98.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: October 2, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–24361 Filed 10–8–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development Initial 

Review Group, Biobehavioral and Behavioral 

Sciences Subcommittee. 

Date: November 17–18, 2009. 

Time: 9 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Renaissance Mayflower Hotel, 1127 

Connecticut Avenue, NW., Washington, DC 

20036. 

Contact Person: Marita R. Hopmann, PhD, 

Scientific Review Officer, Division of 

Scientific Review, Eunice Kennedy Shriver 

National Institute of Child Health and 

Human Development, NIH, 6100 Executive 

Boulevard, Room 5B01, Bethesda, MD 20892, 

(301) 435–6911, hopmannm@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: October 2, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–24359 Filed 10–8–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

National Advisory Council for 

Healthcare Research and Quality: 

Request for Nominations for Public 

Members 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Request for nominations for 

public members. 

SUMMARY: Section 931 of the Public 

Health Service Act (PHS Act), 42 U.S.C. 

299c, established a National Advisory 

Council for Healthcare Research and 

Quality (the Council). The Council is to 

advise the Secretary of HHS (Secretary) 

and the Director of the Agency for 

Healthcare Research and Quality 

(AHRQ) on matters related to activities 

of the Agency to improve the quality, 

safety, efficiency, and effectiveness of 

health care for all Americans. 

Seven current members’ terms will 

expire in November 2009. To fill these 

positions in accordance with the 

legislative mandate establishing the 

Council, we are seeking individuals 

who are distinguished: (1) In the 

conduct of research, demonstration 

projects, and evaluations with respect to 

health care; (2) in the fields of health 

care quality research or health care 

improvement; (3) in the practice of 

medicine; (4) in other health 

professions; (5) in representing the 

private health care sector (including 

health plans, providers, and purchasers) 

or administrators of health care delivery 

systems; (6) in the fields of health care 

economics, information systems, law, 

ethics, business, or public policy; and 

(7) in representing the interests of 

patients and consumers of health care. 

Individuals are particularly sought with 

experience and success in activities 

specified in the summary above. 

DATES: Nominations should be received 

on or before Friday, November 20, 2009. 

ADDRESSES: Nominations should be sent 

to Ms. Deborah Queenan, AHRQ, 540 

Gaither Road, Room 3238, Rockville, 

Maryland 20850. Nominations also may 

be faxed to (301) 427–1341. 

mstockstill on DSKH9S0YB1PROD with NOTICES